The LUNGevity Conversations that Count speaker series offers an opportunity to stay informed, engage in critical discussions, and learn from leading experts advancing lung cancer care for people who experience barriers to accessing high-quality care.
In August, we welcomed Carl Grey, MD, Medical Director at Louisiana Aetna Medicaid and Adjunct Professor at Atrium Health-Wake Forest School of Medicine.
As advances in cancer treatment help people live longer, clinicians must balance effective long-term pain relief with the risks of opioid tolerance, dependence, misuse, and opioid use disorder. In this conversation, Dr. Grey shares practical strategies for safer, individualized opioid prescribing for people with advanced cancer, including opioid rotation, non-opioid options, monitoring, and the potential role of buprenorphine.
More Conversations that Count: